UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement | |||
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||
☐ | Definitive Proxy Statement | |||
☒ | Definitive Additional Materials | |||
☐ | Soliciting Material Pursuant to § 240.14a-12 | |||
BAUSCH HEALTH COMPANIES INC. | ||||
(Name of Registrant as Specified In Its Charter) | ||||
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant) | ||||
Payment of Filing Fee (Check the appropriate box) | ||||
☒ | No fee required. | |||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
(1) | Title of each class of securities to which transaction applies:
| |||
(2) | Aggregate number of securities to which transaction applies:
| |||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
(4) | Proposed maximum aggregate value of transaction:
| |||
(5) | Total fee paid:
| |||
☐ | Fee paid previously with preliminary materials. | |||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
(1) | Amount Previously Paid:
| |||
(2) | Form, Schedule or Registration Statement No.:
| |||
(3) | Filing Party:
| |||
(4) | Date Filed:
|
Your Vote Counts! | ||||||
BAUSCH HEALTH COMPANIES INC. | ||||||
2021 Annual Meeting
Vote by April 23, 2021
11:59 PM EDT | ||||||
BAUSCH HEALTH COMPANIES INC.
ATTN: CHRISTINA M. ACKERMANN
2150 SAINT ELZEAR BLVD. WEST LAVAL, QUEBEC H7L 4A8 CANADA |
| |||||
D37263-P49532
|
You invested in BAUSCH HEALTH COMPANIES INC. and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To Be Held on April 27, 2021.
Get informed before you vote
View the Notice of Annual Meeting of Shareholders and Management Proxy Circular, Proxy Statement and Annual Report online at www.ProxyVote.com OR you can receive a free paper or email copy of the material(s) only by requesting prior to April 13, 2021. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. You will need to provide your control number when requesting your copy. If sending an email, please include your control number (indicated below) in the subject line. The materials contain instructions on how to attend and/or vote at the virtual meeting. Unless requested, you will not otherwise receive a paper or email copy.
V1
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the shareholder meeting. Please follow the instructions on the reverse side to vote these important matters.
Voting Items | Board Recommends | |||
1. | Election of Directors | |||
1a. | Richard U. De Schutter | For | ||
1b. | D. Robert Hale | For | ||
1c. | Brett Icahn | For | ||
1d. | Dr. Argeris (Jerry) N. Karabelas | For | ||
1e. | Sarah B. Kavanagh | For | ||
1f. | Steven D. Miller | For | ||
1g. | Joseph C. Papa | For | ||
1h. | John A. Paulson | For | ||
1i. | Robert N. Power | For | ||
1j. | Russel C. Robertson | For | ||
1k. | Thomas W. Ross, Sr. | For | ||
1l. | Andrew C. von Eschenbach, M.D. | For | ||
1m. Amy B. Wechsler, M.D. | For | |||
2. | The approval, in an advisory vote, of the compensation of our Named Executive Officers. | For | ||
3. | To appoint PricewaterhouseCoopers LLP as the auditor for the Company to hold office until the close of the 2022 Annual Meeting of Shareholders and to authorize the Company’s Board of Directors to fix the auditor’s remuneration. | For | ||
NOTE: Such other business as may properly come before the meeting or any adjournment or postponement thereof. | ||||
Prefer to receive an email instead? While visiting or voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”. |
D37264-P49532